<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-626" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Minimally Invasive Mitral Valve Surgery</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yandrapalli</surname>
            <given-names>Srikanth</given-names>
          </name>
          <aff>New York Medical College/Westchester Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kaplan</surname>
            <given-names>Jason</given-names>
          </name>
          <aff>MSU/ Mclaren Oakland</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Srikanth Yandrapalli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jason Kaplan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>7</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-626.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Minimally invasive mitral valve surgery involves advanced techniques to repair the mitral valve through smaller incisions, avoiding a full sternotomy. Common approaches include partial sternotomy, right mini-thoracotomy, and robotic-assisted procedures. This method offers reduced postoperative pain, shorter recovery, and better cosmetic results. Cardiopulmonary bypass is typically used, with peripheral femoral cannulation being the most common method. Minimally invasive surgery is suitable for many patients, including those at high surgical risk, and has shown comparable safety and efficacy to traditional open-heart surgery. Clinicians participating in this course enhance their knowledge and skills in minimally invasive mitral valve surgery, including patient selection criteria, surgical techniques, and postoperative management. The course provides clinicians with insights into the latest advancements and best practices, improving their ability to coordinate care within a multidisciplinary team, ultimately leading to better patient outcomes and satisfaction.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify appropriate candidates for minimally invasive mitral valve surgery based on clinical indications and patient characteristics.</p></list-item><list-item><p>Evaluate patients through comprehensive preoperative assessments to ensure minimally invasive mitral valve surgery suitability.</p></list-item><list-item><p>Implement advanced surgical techniques and perioperative management protocols for minimally invasive mitral valve surgery.</p></list-item><list-item><p>Communicate&#x000a0;with allied health professionals to coordinate comprehensive care plans for patients undergoing minimally invasive mitral valve surgery.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=626&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=626">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-626.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Recent medical advances have helped the United States (US) population with comorbidities live longer than previously possible. As the aging population expands, the incidence of degenerative heart disease and valvular disease has increased.<xref ref-type="bibr" rid="article-626.r1">[1]</xref> Mitral valve disease is&#x000a0;1 of the most common valvular anomalies and is often concomitant with aortic valve disease. Due to the center of the heart and association with other comorbidities that increase frailty, many patients are at high surgical risk and necessitate alternative therapeutic options.<xref ref-type="bibr" rid="article-626.r1">[1]</xref> Up to 50% of patients with moderate to severe mitral regurgitation (MR) are not considered surgical candidates.<xref ref-type="bibr" rid="article-626.r2">[2]</xref> Medical management in&#x000a0;MR has poor outcomes, with a 1-year mortality rate of 20%, a 5-year mortality rate of 50%, and a high hospitalization rate due to heart failure.<xref ref-type="bibr" rid="article-626.r2">[2]</xref></p>
        <p>In recent years, the advent of minimally invasive mitral valve repair provides a necessary therapeutic option for patients with symptomatic mitral valve disease. Additionally, results from minimally invasive mitral valve repair studies have shown that the procedure preserves cardiac structure and function when implemented early. Minimally invasive surgery through right mini-thoracotomy has become the global standard for treating mitral valve disease, especially in high-volume centers. Recently, the range of indications for this approach has expanded to include more fragile and high-risk patients, as well as those with complex mitral valve conditions and cases of native or prosthetic infective endocarditis. The primary reasons for adopting this minimally invasive technique are to reduce surgical trauma, facilitate quicker postoperative recovery, and lower the risk of surgical wounds and other hospital-acquired infections.<xref ref-type="bibr" rid="article-626.r3">[3]</xref>&#x000a0;</p>
        <p>Enhancements of minimally invasive surgical techniques improved surgical trauma and postoperative recovery, resulting in increased acceptance of these techniques.<xref ref-type="bibr" rid="article-626.r4">[4]</xref>&#x000a0;Different minimally invasive techniques include robotic repair, minimally invasive mitral valve surgery using a right mini-thoracotomy, percutaneous edge-to-edge mitral valve repair, and transcatheter mitral valve replacement (TMVR).&#x000a0;Many patients with symptomatic MR have a poor prognosis due to older age and comorbidities. Minimally invasive surgical approaches to mitral valve repair have provided&#x000a0;essential treatment&#x000a0;options for those at higher risk for surgery. The emergence of transcatheter mitral valve repair and replacement options further pushes the boundary of possibilities. Hence, patients who are not surgical candidates can live longer than possible.<xref ref-type="bibr" rid="article-626.r5">[5]</xref></p>
      </sec>
      <sec id="article-626.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>
<bold>Anatomy of the Mitral Valve</bold>
</p>
        <p>The mitral valve is a critical structure located between the left atrium and the left ventricle of the heart, consisting of several key anatomical components:</p>
        <list list-type="bullet">
          <list-item>
            <p>Valve leaflets
<list list-type="bullet"><list-item><p>The mitral valve has&#x000a0;2 leaflets: anterior (or aortic) and posterior (or mural).</p></list-item><list-item><p>These leaflets are thin, fibrous structures that open and close to regulate blood flow between the left atrium and ventricle.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Chordae tendineae
<list list-type="bullet"><list-item><p>These strong, fibrous cords attach the mitral valve leaflets to the papillary muscles in the left ventricle.</p></list-item><list-item><p>They prevent the valve leaflets from prolapsing into the left atrium during ventricular contraction.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Papillary muscles
<list list-type="bullet"><list-item><p>These muscles are located in the left ventricle and are attached to the chordae tendineae.</p></list-item><list-item><p>Their contraction during systole (ventricular contraction) helps maintain tension on the chordae tendineae, thereby preventing mitral valve prolapse.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Annulus
<list list-type="bullet"><list-item><p>The mitral valve annulus is a fibrous, saddle-shaped&#x000a0;structure that surrounds the valve orifice, provides attachment for the valve leaflets, and helps maintain the valve's shape and integrity during the cardiac cycle.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>Physiology of the Mitral Valve and Associated Pathologies</bold>
</p>
        <p>The mitral valve has an essential function in pressure and volume homeostasis for the heart, showing dynamic changes in geometry during the cardiac cycle.<xref ref-type="bibr" rid="article-626.r6">[6]</xref>&#x000a0;Mitral valve disease can be detrimental and lead to complications like heart failure or atrial fibrillation from left atrial enlargement. Advances in cardiac imaging with 3-dimensional echocardiography have allowed for enhanced visualization of the mitral valve pathology to classify mitral valve pathology better.<xref ref-type="bibr" rid="article-626.r7">[7]</xref>&#x000a0;Mitral valve pathologies primarily involve conditions like mitral stenosis (narrowing of the valve opening) and MR&#x000a0;(leakage of blood back into the left atrium), which are further discussed below:</p>
        <list list-type="bullet">
          <list-item>
            <p>
<bold>Mitral stenosis</bold>
</p>
            <list list-type="bullet">
              <list-item>
                <p>Mitral stenosis occurs when the mitral valve leaflets thicken and become stiff, reducing the valve's ability to open fully during diastole (ventricular relaxation). This obstruction impedes blood flow from the left atrium to the left ventricle, causing increased pressure in the left atrium and overall pulmonary circulation.</p>
              </list-item>
              <list-item>
                <p>Reduced diastolic filling of the left ventricle leads to decreased stroke volume and cardiac output. The elevated left atrial pressure may cause pulmonary congestion, leading to symptoms such as dyspnea, orthopnea, and pulmonary edema.</p>
              </list-item>
              <list-item>
                <p>This condition is most commonly due to rheumatic heart disease.<xref ref-type="bibr" rid="article-626.r8">[8]</xref>&#x000a0;</p>
              </list-item>
              <list-item>
                <p>The preferred modality for treating mitral stenosis is percutaneous balloon mitral valvuloplasty to increase the valve area and relieve the pressure gradient between the left atria and left ventricle.<xref ref-type="bibr" rid="article-626.r8">[8]</xref></p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>
<bold>Mitral regurgitation</bold>
</p>
            <list list-type="bullet">
              <list-item>
                <p>MR&#x000a0;occurs when the mitral valve leaflets fail to close properly during systole, allowing blood to leak back into the left atrium from the left ventricle. This leakage increases the volume load on the left atrium and may cause left ventricle volume overload.</p>
              </list-item>
              <list-item>
                <p>During systole, some blood flows back into the left atrium instead of being pumped into the systemic circulation. This reduces the effective forward stroke volume and can lead to symptoms of heart failure such as fatigue, dyspnea, and, eventually, left ventricular dysfunction.</p>
              </list-item>
              <list-item>
                <p>MR can be defined as primary or secondary due to the underlying pathology.
<list list-type="bullet"><list-item><p>Primary
<list list-type="bullet"><list-item><p>Per the European Society of Cardiology statement, primary&#x000a0;MR is caused by a defect in the mitral valve apparatus that can be due to a degenerative process like mitral prolapse, flail leaflet, or endocarditis.<xref ref-type="bibr" rid="article-626.r9">[9]</xref></p></list-item></list>
</p></list-item><list-item><p>Secondary
<list list-type="bullet"><list-item><p>Secondary&#x000a0;MR is also known as 'functional MR.' He is defined as an imbalance between closing and tethering forces on the mitral valve secondary to structural heart changes with a structurally normal mitral valve apparatus.<xref ref-type="bibr" rid="article-626.r10">[10]</xref></p></list-item><list-item><p>Causes of secondary MR include dilated cardiomyopathy, ischemic cardiomyopathy, and annular dilation that causes an increase in the mitral annulus diameter.<xref ref-type="bibr" rid="article-626.r10">[10]</xref></p></list-item></list>
</p></list-item></list>
</p>
              </list-item>
              <list-item>
                <p>Management options differ between primary and secondary MR, requiring proper evaluation and classification of the pathology.</p>
              </list-item>
            </list>
          </list-item>
        </list>
      </sec>
      <sec id="article-626.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold>Indications for Minimally Invasive Mitral Valve Surgery Overview and Guidelines</bold>
</p>
        <p>According to the American College of Cardiology and the European Society of Cardiology recommendations, the management of MR is determined by the severity and pathology of the disease.<xref ref-type="bibr" rid="article-626.r11">[11]</xref><xref ref-type="bibr" rid="article-626.r12">[12]</xref> For acute MR, a trial of medical therapy is indicated. Patients who are asymptomatic with a left ventricular ejection fraction (LVEF) greater than 60% can be monitored without immediate surgical intervention. However, patients with chronic MR who exhibit symptoms despite medical management or who have poor ventricular function should be considered for surgery due to their poor prognosis. Mitral valve repair remains the gold standard surgical technique for treating significant MR, offering high patient satisfaction, shorter hospital stays, low perioperative morbidity and mortality rates, and excellent long-term outcomes.<xref ref-type="bibr" rid="article-626.r13">[13]</xref><xref ref-type="bibr" rid="article-626.r14">[14]</xref>&#x000a0;</p>
        <p>
<bold>Primary MR</bold>
</p>
        <p>For primary MR, surgery is recommended for patients who are symptomatic with chronic severe MR (stage D) and LVEF greater than 30%.&#x000a0;Surgery is also indicated for asymptomatic patients with left ventricular dysfunction, characterized by a left ventricular end-systolic dimension (LVESD) of 40 to 45 mm or greater or LVEF less than 60% (class I, level B). The primary treatment of primary MR is surgical repair. However,&#x000a0;the&#x000a0;European guidelines suggest that the percutaneous edge-to-edge procedure may be considered for patients with symptomatic severe primary MR who meet the echocardiographic eligibility criteria and are deemed inoperable or at high surgical risk by the heart team (class IIb, level C).<xref ref-type="bibr" rid="article-626.r12">[12]</xref>&#x000a0;</p>
        <p>
<bold>Secondary MR</bold>
</p>
        <p>In cases of secondary MR, surgical correction has not demonstrated improved survival. However, percutaneous edge-to-edge repair has shown benefits in improving the quality of life and survival for patients with heart failure and moderate to severe MR who remain symptomatic despite optimal medical management.&#x000a0;</p>
        <p>
<bold>Minimally Invasive Mitral Valve Surgery</bold>
</p>
        <p>Minimally invasive mitral valve surgery indications have expanded significantly, particularly in high-volume institutions. This approach now includes patients who are more fragile and high-risk, as well as those with increasingly complex&#x000a0;mitral valve disease, such as infective endocarditis. More than 50% of patients with infective endocarditis require surgical intervention to prevent severe complications such as heart failure, uncontrolled infection, and systemic embolism. Both American&#x000a0;and European guidelines advocate for early surgical intervention when necessary. Advances in early surgical planning, intensive care, and postoperative management have significantly improved outcomes for these patients, although perioperative mortality and morbidity rates remain high. The rationale for using a minimally invasive approach in those who are high-risk is to reduce surgical trauma, facilitate quicker postoperative recovery, and lower the risk of surgical wounds and hospital-acquired infections.<xref ref-type="bibr" rid="article-626.r3">[3]</xref></p>
        <p>Minimally invasive surgical techniques for&#x000a0;mitral valve repair, such as right mini-thoracotomy, robotic-assisted repair, and percutaneous edge-to-edge mitral valve repair, are increasingly favored due to their benefits in reducing postoperative complications and enhancing recovery, especially in patients who are not ideal candidates for traditional open surgery. As technology advances and transcatheter aortic valve replacement becomes more popular, devices for&#x000a0;TMVR are being developed as future therapeutic options, further expanding therapeutic possibilities for patients with MR.</p>
      </sec>
      <sec id="article-626.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Many factors must be weighed when considering minimally invasive surgical mitral repair versus TMVR. Minimally invasive techniques, such as mini-thoracotomy and robotic surgery, offer benefits over traditional surgical methods, including less postoperative pain, shorter recovery times, and better cosmetic results.<xref ref-type="bibr" rid="article-626.r4">[4]</xref> However, these approaches are technically complex and require significant practice to achieve comparable outcomes.<xref ref-type="bibr" rid="article-626.r15">[15]</xref>&#x000a0;Despite the advantages, not all patients are suitable candidates for minimally invasive mitral valve surgery. Specific contraindications must be considered. While minimally invasive&#x000a0;mitral valve surgery via mini-thoracotomy can be performed along with atrial fibrillation ablation or right-sided heart procedures, concomitant surgeries such as coronary artery bypass grafting (CABG) and aortic valve replacement necessitate a traditional median sternotomy approach.<xref ref-type="bibr" rid="article-626.r16">[16]</xref> Other contraindications for minimally invasive&#x000a0;mitral valve surgery include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Previous right thoracotomy</p>
          </list-item>
          <list-item>
            <p>Significant aortic root dilatation</p>
          </list-item>
          <list-item>
            <p>Moderate to severe aortic regurgitation</p>
          </list-item>
          <list-item>
            <p>Right ventricular dysfunction</p>
          </list-item>
          <list-item>
            <p>Fixed pulmonary hypertension (greater than 60 mm Hg)</p>
          </list-item>
          <list-item>
            <p>Severe generalized peripheral artery disease</p>
          </list-item>
          <list-item>
            <p>Calcification of the aortic root or mitral annulus</p>
          </list-item>
          <list-item>
            <p>Symptomatic cerebrovascular disease or recent stroke</p>
          </list-item>
          <list-item>
            <p>Significant bleeding disorders</p>
          </list-item>
          <list-item>
            <p>Severe liver dysfunction</p>
          </list-item>
        </list>
        <p>For robotic mitral valve repair, relative contraindications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild aortic stenosis or regurgitation</p>
          </list-item>
          <list-item>
            <p>Limited peripheral artery disease</p>
          </list-item>
          <list-item>
            <p>Variable pulmonary hypertension (greater than 50 mm Hg)</p>
          </list-item>
          <list-item>
            <p>Chest deformity (eg, pectus excavatum or scoliosis)</p>
          </list-item>
          <list-item>
            <p>Coronary artery disease</p>
          </list-item>
          <list-item>
            <p>Moderate pulmonary dysfunction&#x000a0;<xref ref-type="bibr" rid="article-626.r17">[17]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Given that mitral valve disease is more prevalent in patients 65 and older, many patients are not suitable candidates for surgical intervention. They may instead be referred for percutaneous edge-to-edge mitral valve repair. This transcutaneous approach provides an alternative for patients with MR who are not candidates for traditional surgery. However, this procedure is contraindicated in patients who cannot tolerate procedural anticoagulation or postprocedural antiplatelet therapy, those with active endocarditis, rheumatic mitral valve disease, and those with intracardiac or venous thrombus.</p>
      </sec>
      <sec id="article-626.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>Treating mitral valve disease requires effective multidisciplinary communication. One key distinction between the minimally invasive surgical approach and percutaneous edge-to-edge mitral valve repair is the team performing the procedure. Cardiothoracic surgeons conduct minimally invasive and robotic surgeries, while interventional cardiologists typically handle transcatheter repairs. In cases where complications arise during percutaneous edge-to-edge mitral valve repair, cardiothoracic surgery collaborates with interventional cardiology to convert the procedure to a mediastinotomy if necessary. This collaboration ensures comprehensive care and enhances patient outcomes.&#x000a0;</p>
      </sec>
      <sec id="article-626.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>In preparation for minimally invasive mitral valve surgery, a patient must undergo a comprehensive diagnostic workup and therapeutic medical management by a cardiologist. This includes an echocardiogram, which can be performed via a transthoracic or transesophageal approach to visualize the heart structures and understand the anatomy of the mitral valve. Additional workup involves optimizing the management of other comorbidities. Since general anesthesia is required for both minimally invasive surgery and percutaneous edge-to-edge mitral valve repair, patients need clearance from their cardiologist before the procedure. For a surgical mitral valve repair, the patient meets with the cardiothoracic surgeon and anesthesiologist before the procedure to prepare for the operating room. Patients scheduled for percutaneous edge-to-edge mitral valve repair meet with an interventional cardiologist and anesthesiologist to prepare for a hybrid operating room. This preoperative coordination ensures that all patient care aspects are meticulously planned and managed, optimizing surgical outcomes and patient safety.</p>
      </sec>
      <sec id="article-626.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Minimally invasive mitral valve surgery avoids a full sternotomy. It can be performed through several approaches, including a partial sternal split (lower J-shaped, or less commonly, upper hemisternotomy), a right mini-thoracotomy incision, and multiple smaller incisions for a robotic approach.<xref ref-type="bibr" rid="article-626.r17">[17]</xref>&#x000a0;The standard incision for a mini-thoracotomy is made in the fourth intercostal space, but newer techniques utilize periareolar incisions for select patients. Robotic instrumentation can facilitate an endoscopic approach with incisions no larger than 1.5 cm for instrument placement.&#x000a0;Complete procedural details are beyond the scope of this review and discussed elsewhere.<xref ref-type="bibr" rid="article-626.r4">[4]</xref><xref ref-type="bibr" rid="article-626.r17">[17]</xref> Myocardial protection and cardioplegia delivery are crucial, as cross-clamp and pump times are longer than open mitral valve surgery.</p>
        <p>
<bold>Right Mini-thoracotomy Approach</bold>
</p>
        <p>The most common approach is through a right mini-thoracotomy.<xref ref-type="bibr" rid="article-626.r4">[4]</xref> This requires cardiopulmonary bypass, usually achieved through peripheral femorofemoral cannulation, though direct aortic cannulation via the mini-thoracotomy incision is also an option.<xref ref-type="bibr" rid="article-626.r18">[18]</xref> Special techniques for cardiopulmonary bypass include vacuum assist, smaller cannulas, and transthoracic aortic cross clamps. A partial sternal split approach allows for central aortic cannulation, while a limited right thoracotomy or multiple smaller incisions for a robotic procedure requires femoral arterial and venous cannulation.<xref ref-type="bibr" rid="article-626.r4">[4]</xref></p>
        <p>
<bold>Percutaneous Edge-to-Edge Mitral Valve Repair</bold>
</p>
        <p>This approach benefits from not requiring cardiopulmonary bypass&#x000a0;and involves a 5-step process using transesophageal echocardiography guidance:</p>
        <list list-type="bullet">
          <list-item>
            <p>Baseline imaging</p>
          </list-item>
          <list-item>
            <p>Transseptal puncture</p>
          </list-item>
          <list-item>
            <p>Positioning of the clip in the left atrium above the affected mitral leaflet
<list list-type="bullet"><list-item><p>Multiple clips may be deployed to achieve a good result.<xref ref-type="bibr" rid="article-626.r19">[19]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Leaflet grasp and deployment of the device</p>
          </list-item>
          <list-item>
            <p>Postdeployment assessment&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>TMVR</bold>
</p>
        <p>TMVR devices are currently undergoing clinical trials in the US. Results from the first-in-human study conducted in Vancouver, Canada, between August 2017 and August 2018 showed promise. The Abbott Tendyne TMVR device was approved for use in Europe in January 2020 and is undergoing the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic MR (SUMMIT) clinical trial in the US for potential approval. Various techniques and the success of TMVR devices are still being investigated. These minimally invasive approaches offer significant advantages, including reduced postoperative pain, shorter recovery times, and better cosmetic results. However, they are technically complex and require considerable expertise to achieve outcomes comparable to traditional surgery.</p>
      </sec>
      <sec id="article-626.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Due to increased technical demands, minimally invasive mitral valve surgery typically requires longer cardiopulmonary bypass times than conventional sternotomy. Few underpowered randomized comparisons exist between traditional and minimally invasive techniques regarding clinical outcomes and postoperative complications. Studies suggest that the increased cardiopulmonary bypass time, with retrograde flow in the aorta, presents a stroke risk similar to traditional approaches. The risks of mortality, renal failure, wound infection, reoperation for bleeding, aortic dissection, myocardial infarction, atrial fibrillation, and 30-day readmission are reported as not statistically different between minimally invasive and conventional surgical approaches when surgically appropriate indications and proper patient selection are present. Stroke rates for minimally invasive mitral valve repair have been reported between 1% and 2.6%. Peripheral cannulation can lead to soft tissue infections in 1% to 7% of patients.<xref ref-type="bibr" rid="article-626.r20">[20]</xref> Additionally, a small subset of patients may require conversion to median sternotomy intraoperatively due to complications.</p>
        <p>The percutaneous edge-to-edge mitral valve repair device is relatively safe, as the Endovascular Valve Edge-to-Edge Repair Study (EVEREST) trial demonstrated.<xref ref-type="bibr" rid="article-626.r21">[21]</xref> This device shows low rates of resuscitation, myocardial infarction, renal failure, and pulmonary embolism, ranging from 0% to 1%. Stroke risk is between 0.4% and 1.4%, and significant bleeding risk is between 1.1% and 7.4%. Major bleeding is a frequent complication due to the necessity of anticoagulation. Procedural complications include the potential dislocation of an existing pacemaker during transseptal puncture, which can be mitigated by verifying the location with fluoroscopy and echocardiography. Transseptal puncture generally does not require closure as the risk of pericardial tamponade postoperatively is low. Single-leaflet device detachment, occurring in 0% to 4.8% of cases, is the most common implantation complication. Rare complications include clip embolization requiring surgical retrieval, thrombus formation on the clip, and direct leaflet damage. Mitral stenosis may result from clip placement but is considered acceptable based on the interventional team's judgment. Achieving an adequate reduction of&#x000a0;MR may warrant accepting a higher transmitral valve gradient, resulting in better long-term outcomes.</p>
      </sec>
      <sec id="article-626.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>A minimally invasive surgical approach to mitral valve repair is the preferred option for mitral valve surgery in surgically acceptable candidates. It provides essential treatment options for those at higher risk for surgery. Available data suggest that procedural and long-term outcomes and the safety of the minimally invasive approach are comparable to conventional mitral valve surgery. Therefore, &#x000a0;a minimally invasive approach should always be considered for&#x000a0;patients requiring surgery for primary MR. The percutaneous edge-to-edge mitral valve repair procedure may be considered for patients with symptomatic severe primary MR who fulfill the echocardiographic eligibility criteria and are judged inoperable or have a high surgical risk by the heart team. For secondary MR, surgical repair is not typically recommended. As transcatheter aortic valve replacement becomes more popular, TMVR devices are being developed as future therapeutic options. Future research should identify the best approach for minimally invasive surgery and provide comparative data with transcatheter and open surgical options regarding safety and efficacy for both primary and secondary MR.</p>
      </sec>
      <sec id="article-626.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Successful minimally invasive mitral valve surgery hinges on a highly skilled and coordinated interprofessional team. Physicians, including cardiothoracic surgeons and cardiologists, must possess expertise in advanced surgical techniques and patient assessment to determine suitability for minimally invasive approaches. Advanced practitioners are crucial in preoperative evaluations, postoperative care, and patient education. Nurses are integral in providing perioperative care, monitoring patient status, and ensuring adherence to postoperative protocols. Pharmacists contribute by managing medications, particularly anticoagulation therapy, which is critical for patient safety and optimal outcomes. Effective interprofessional communication and care coordination are vital for enhancing patient-centered care. Regular team meetings and multidisciplinary tumor boards facilitate comprehensive treatment planning and promptly address any complications. Utilizing standardized communication tools ensures precise and consistent information exchange among team members. Coordinated care plans that include detailed preoperative workups, intraoperative management strategies, and postoperative follow-up protocols help optimize patient outcomes. By working collaboratively, the healthcare team can minimize risks, reduce recovery times, and improve patient safety and satisfaction.</p>
      </sec>
      <sec id="article-626.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=626&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=626">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/626/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=626">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-626.s13">
        <title>References</title>
        <ref id="article-626.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rostagno</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Heart valve disease in elderly.</article-title>
            <source>World J Cardiol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>26</day>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-83</page-range>
            <pub-id pub-id-type="pmid">30820277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goel</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poddar</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Ige</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bdair</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Anabtawi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rahim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Whitlow</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Tuzcu</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Gillinov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blackstone</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Smedira</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Jan</month>
            <day>21</day>
            <volume>63</volume>
            <issue>2</issue>
            <fpage>185</fpage>
            <page-range>185-6</page-range>
            <pub-id pub-id-type="pmid">24036029</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pocar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brenna</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parrella</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baldarelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aloi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Costamagna</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trompeo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Vairo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alunni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salizzoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Minimally Invasive Surgery: Standard of Care for Mitral Valve Endocarditis.</article-title>
            <source>Medicina (Kaunas)</source>
            <year>2023</year>
            <month>Aug</month>
            <day>08</day>
            <volume>59</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">37629726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Praet</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Stamm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000fc;ndermann</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unbehaun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montagner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nazari Shafti</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kempfert</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review.</article-title>
            <source>Interv Cardiol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-19</page-range>
            <pub-id pub-id-type="pmid">29593831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malik</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Zaid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yandrapalli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aronow</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>GHL</given-names>
              </name>
            </person-group>
            <article-title>Trends and Outcomes With Transcatheter Versus Surgical Mitral Valve Repair in Patients &#x02265;80 Years of Age.</article-title>
            <source>Am J Cardiol</source>
            <year>2020</year>
            <month>Apr</month>
            <day>01</day>
            <volume>125</volume>
            <issue>7</issue>
            <fpage>1083</fpage>
            <page-range>1083-1087</page-range>
            <pub-id pub-id-type="pmid">31982103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Veronesi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Corsi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sugeng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mor-Avi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Caiani</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Weinert</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lamberti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>A study of functional anatomy of aortic-mitral valve coupling using 3D matrix transesophageal echocardiography.</article-title>
            <source>Circ Cardiovasc Imaging</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-31</page-range>
            <pub-id pub-id-type="pmid">19808561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in understanding and managing mitral valve disease.</article-title>
            <source>F1000Res</source>
            <year>2019</year>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31588355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harb</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Mitral Valve Disease: a Comprehensive Review.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>73</fpage>
            <pub-id pub-id-type="pmid">28688022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Antunes</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bongiorni</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Casalta</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Del Zotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dulgheru</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>El Khoury</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Plonska-Gosciniak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roos-Hesselink</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Snygg-Martin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Thuny</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tornos Mas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vilacosta</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).</article-title>
            <source>Eur Heart J</source>
            <year>2015</year>
            <month>Nov</month>
            <day>21</day>
            <volume>36</volume>
            <issue>44</issue>
            <fpage>3075</fpage>
            <page-range>3075-3128</page-range>
            <pub-id pub-id-type="pmid">26320109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levine</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Schwammenthal</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts.</article-title>
            <source>Circulation</source>
            <year>2005</year>
            <month>Aug</month>
            <day>02</day>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>745</fpage>
            <page-range>745-58</page-range>
            <pub-id pub-id-type="pmid">16061756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Jneid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Jun</month>
            <day>20</day>
            <volume>135</volume>
            <issue>25</issue>
            <fpage>e1159</fpage>
            <page-range>e1159-e1195</page-range>
            <pub-id pub-id-type="pmid">28298458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bax</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hamm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Holm</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lansac</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rodriguez Mu&#x000f1;oz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rosenhek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;gren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tornos Mas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walther</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wendler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2017 ESC/EACTS Guidelines for the management of valvular heart disease.</article-title>
            <source>Eur Heart J</source>
            <year>2017</year>
            <month>Sep</month>
            <day>21</day>
            <volume>38</volume>
            <issue>36</issue>
            <fpage>2739</fpage>
            <page-range>2739-2791</page-range>
            <pub-id pub-id-type="pmid">28886619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welp</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive mitral valve repair.</article-title>
            <source>Curr Opin Anaesthesiol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-71</page-range>
            <pub-id pub-id-type="pmid">24366064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oezpeker</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Hoefer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gollmann-Tepekoeylue</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johannes</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clemens</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Suat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Adel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sasa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grimm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonaros</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Isolated annuloplasty in elderly patients with secondary mitral valve regurgitation: short- and long-term outcomes with a less invasive approach.</article-title>
            <source>Front Cardiovasc Med</source>
            <year>2023</year>
            <volume>10</volume>
            <fpage>1193156</fpage>
            <pub-id pub-id-type="pmid">37915742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holzhey</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Seeburger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Misfeld</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>FW</given-names>
              </name>
            </person-group>
            <article-title>Learning minimally invasive mitral valve surgery: a cumulative sum sequential probability analysis of 3895 operations from a single high-volume center.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Jul</month>
            <day>30</day>
            <volume>128</volume>
            <issue>5</issue>
            <fpage>483</fpage>
            <page-range>483-91</page-range>
            <pub-id pub-id-type="pmid">23804253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akowuah</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Hancock</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kharatikoopaei</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vale</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fernandez-Garcia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ogundimu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wagnild</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mathias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walmsley</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Howe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kasim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Zacharias</surname>
                <given-names>J</given-names>
              </name>
              <collab>UK Mini Mitral Trial Investigators</collab>
            </person-group>
            <article-title>Minithoracotomy vs Conventional Sternotomy for Mitral Valve Repair: A Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2023</year>
            <month>Jun</month>
            <day>13</day>
            <volume>329</volume>
            <issue>22</issue>
            <fpage>1957</fpage>
            <page-range>1957-1966</page-range>
            <pub-id pub-id-type="pmid">37314276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marin Cuartas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Javadikasgari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pfannmueller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Seeburger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gillinov</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Mitral valve repair: Robotic and other minimally invasive approaches.</article-title>
            <source>Prog Cardiovasc Dis</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>394</fpage>
            <page-range>394-404</page-range>
            <pub-id pub-id-type="pmid">29128572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kastengren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Svenarud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ahlsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dal&#x000e9;n</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive mitral valve surgery is associated with a low rate of complications.</article-title>
            <source>J Intern Med</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>286</volume>
            <issue>6</issue>
            <fpage>614</fpage>
            <page-range>614-626</page-range>
            <pub-id pub-id-type="pmid">31502720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherif</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Paranskaya</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yuecel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kische</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>D'Ancona</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neuhausen-Abramkina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ortak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>&#x000d6;ner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>MitraClip step by step; how to simplify the procedure.</article-title>
            <source>Neth Heart J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-130</page-range>
            <pub-id pub-id-type="pmid">27933588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>de Kroon</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Post</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kelder</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Schut</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Saouti</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van Putte</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Minimally invasive mitral valve surgery: a systematic safety analysis.</article-title>
            <source>Open Heart</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">33046594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-626.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elmariah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smart</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Trento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Apruzzese</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fail</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smalling</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Heimansohn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ailawadi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Acker</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Silvestry</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glower</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <collab>EVEREST II Investigators</collab>
            </person-group>
            <article-title>Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>29</day>
            <volume>66</volume>
            <issue>25</issue>
            <fpage>2844</fpage>
            <page-range>2844-2854</page-range>
            <pub-id pub-id-type="pmid">26718672</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
